View All

Blog - Pharmaceutical Preparation

Merck's Experimental HIV Drug Combination Achieves Key Milestones

Dec 19, 2024

Merck's new HIV drug combination meets key clinical trial endpoints, offering hope for more effective HIV treatments.

Novo Holdings Completes $16.5 Billion Catalent Takeover

Dec 18, 2024

Novo Holdings finalizes a $16.5 billion takeover of Catalent, marking a significant milestone in the pharmaceutical industry and strengthening its healthcare sector presence.

Positive Clinical Trials Propel Teva and Sanofi Shares Higher

Dec 17, 2024

166

Teva and Sanofi shares surged as their joint clinical trial for ulcerative colitis and Crohn's disease treatment showed promising results, achieving key endpoints.

Pfizer's 2025 Revenue Projections Align with Analysts' Expectations

Dec 17, 2024

560

Pfizer forecasts 2025 sales between $61B-$64B, meeting Wall Street expectations, amid strategic moves like cost cuts and leadership in R&D.

Goldman Sachs Asset Management Set to Acquire Synthon International from BC Partners

Dec 15, 2024

410

Goldman Sachs Asset Management is close to acquiring Synthon International from BC Partners for around EUR2 billion, highlighting the growing interest in the pharmaceutical industry.

Ro and Eli Lilly Join Forces to Make Zepbound Vials Affordable

Dec 11, 2024

254

Ro collaborates with Eli Lilly to offer affordable Zepbound vials, enhancing weight loss drug accessibility and affordability.